Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q2 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.